Presentation is loading. Please wait.

Presentation is loading. Please wait.

Oral quinine sulfate for the treatment of electrical storm and prevention of recurrent shocks in Brugada syndrome after failed cilostazol therapy  Jayaprakash.

Published byMichelina Antonini Modified over 5 years ago

Similar presentations

Presentation on theme: "Oral quinine sulfate for the treatment of electrical storm and prevention of recurrent shocks in Brugada syndrome after failed cilostazol therapy  Jayaprakash."— Presentation transcript:

1 Oral quinine sulfate for the treatment of electrical storm and prevention of recurrent shocks in Brugada syndrome after failed cilostazol therapy  Jayaprakash Shenthar, MD, FACC, FRCP (Lond), Siva Sankara Chakali, MD, Debashish Acharya, MD, Javed Parvez, MD, Bharatraj Banavalikar, MD  HeartRhythm Case Reports  Volume 3, Issue 10, Pages (October 2017) DOI: /j.hrcr Copyright © 2017 Heart Rhythm Society Terms and Conditions

2 Figure 1 Details of implantable cardioverter-defibrillator (ICD) interrogation at the time of presentation. A: The log of therapies delivered by the ICD reveals that from to hours the patient has 10 shocks delivered for ventricular fibrillation (VF). B: Intracardiac electrogram of 1 of the above episodes from the device shows a ventricular ectopic beat falling on the T wave, initiating a polymorphic ventricular tachycardia (VT) degenerating into VF correctly identified by the device. The patient received an appropriate therapy with a 35-joule shock terminating the VF (not in the picture). HeartRhythm Case Reports 2017 3, DOI: ( /j.hrcr ) Copyright © 2017 Heart Rhythm Society Terms and Conditions

3 Figure 2 Interrogation data from the implantable cardioverter-defibrillator before the present episode while on oral cilostazol therapy after the first electrical storm (red block arrow). While on cilostazol, the patient had 1 electrical storm (blue arrowhead), 1 episode of ventricular fibrillation (VF, red star), 9 episodes of ventricular tachycardia (VT) not requiring therapy, and 17 episodes of superventricular tachycardia (SVT). HeartRhythm Case Reports 2017 3, DOI: ( /j.hrcr ) Copyright © 2017 Heart Rhythm Society Terms and Conditions

4 Figure 3 Twelve-lead electrocardiograms (ECGs) of the patient. A: ECG at presentation has type 1 Brugada pattern with marked ST elevation seen in V1 to V3. B: ECG done 14 hours after initiation of isoprenaline infusion shows persistent type 1 Brugada pattern but with the resolution of ST segment. Ventricular ectopic beat is also noted. C: ECG on follow-up while on quinine therapy shows incomplete right bundle branch block pattern with complete resolution of ST segment. HeartRhythm Case Reports 2017 3, DOI: ( /j.hrcr ) Copyright © 2017 Heart Rhythm Society Terms and Conditions

Download ppt "Oral quinine sulfate for the treatment of electrical storm and prevention of recurrent shocks in Brugada syndrome after failed cilostazol therapy  Jayaprakash."

Similar presentations

Implantation of the subcutaneous implantable cardioverter-defibrillator with retroperitoneal generator placement in a child with hypoplastic left heart.

Implantation of the subcutaneous implantable cardioverter-defibrillator with retroperitoneal generator placement in a child with hypoplastic left heart.
Abnormal epicardial electrophysiologic substrate in patients with early repolarization pattern and reduced left ventricular systolic function: A report.

Abnormal epicardial electrophysiologic substrate in patients with early repolarization pattern and reduced left ventricular systolic function: A report.
Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator  Mohammad-Ali.

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator  Mohammad-Ali.
Inhibition of pacing in a dependent patient with an implantable cardioverter-defibrillator and a left ventricular assist device  Michele Murphy, MD, Timothy.

Inhibition of pacing in a dependent patient with an implantable cardioverter-defibrillator and a left ventricular assist device  Michele Murphy, MD, Timothy.
Ellis Rochelson, MD, Lynn Nappo, RN, Robert H. Pass, MD 

Ellis Rochelson, MD, Lynn Nappo, RN, Robert H. Pass, MD 
Volume 11, Issue 1, Pages (January 2014)

Volume 11, Issue 1, Pages (January 2014)
Inhibition of pacing in a dependent patient with an implantable cardioverter-defibrillator and a left ventricular assist device  Michele Murphy, MD, Timothy.

Inhibition of pacing in a dependent patient with an implantable cardioverter-defibrillator and a left ventricular assist device  Michele Murphy, MD, Timothy.
Erroneous shock by an AED: Importance of obtaining AED tracing to prevent inappropriate ICD implantation  Brian J. Cross, MD, Mark S. Link, MD, FHRS 

Erroneous shock by an AED: Importance of obtaining AED tracing to prevent inappropriate ICD implantation  Brian J. Cross, MD, Mark S. Link, MD, FHRS 
Appearance of J wave in the inferolateral leads and ventricular fibrillation provoked by mild hypothermia in a patient with Brugada syndrome  Yasuaki.

Appearance of J wave in the inferolateral leads and ventricular fibrillation provoked by mild hypothermia in a patient with Brugada syndrome  Yasuaki.
A unique case of pulmonary embolism presenting as a paroxysmal atrial tachycardia instigated only by recumbency and stooping  Nagesh Chopra, MD  HeartRhythm.

A unique case of pulmonary embolism presenting as a paroxysmal atrial tachycardia instigated only by recumbency and stooping  Nagesh Chopra, MD  HeartRhythm.
Swimming pool saline chlorination units and implantable cardiac devices: A source for potentially fatal electromagnetic interference  John Wight, BS,

Swimming pool saline chlorination units and implantable cardiac devices: A source for potentially fatal electromagnetic interference  John Wight, BS,
Inappropriate shock from delayed T-wave oversensing by a subcutaneous implantable cardioverter-defibrillator after septal myectomy for hypertrophic cardiomyopathy 

Inappropriate shock from delayed T-wave oversensing by a subcutaneous implantable cardioverter-defibrillator after septal myectomy for hypertrophic cardiomyopathy 
Recurrent commotio cordis: Déjà vu

Recurrent commotio cordis: Déjà vu
A case of paroxysmal atrioventricular block–induced cardiac arrest

A case of paroxysmal atrioventricular block–induced cardiac arrest
Challenges in the diagnosis and management of idiopathic ventricular fibrillation  Jonathan Lipton, MD, PhD, George J. Klein, MD, Raymond W. Sy, MBBS,

Challenges in the diagnosis and management of idiopathic ventricular fibrillation  Jonathan Lipton, MD, PhD, George J. Klein, MD, Raymond W. Sy, MBBS,
Ben Ng, MBBS, Robert W. Giles, MBBS, Zal Dastur, BSc, Mark A

Ben Ng, MBBS, Robert W. Giles, MBBS, Zal Dastur, BSc, Mark A
Is it bradycardia or something else causing symptoms?

Is it bradycardia or something else causing symptoms?
Quinidine effective for the management of ventricular and atrial arrhythmias associated with Brugada syndrome  Laura Halperin, BSc, Greg Mellor, MD, Mario.

Quinidine effective for the management of ventricular and atrial arrhythmias associated with Brugada syndrome  Laura Halperin, BSc, Greg Mellor, MD, Mario.
T-wave oversensing during drug challenge test after subcutaneous implantable cardioverter-defibrillator implantation in a patient with Brugada syndrome 

T-wave oversensing during drug challenge test after subcutaneous implantable cardioverter-defibrillator implantation in a patient with Brugada syndrome 
Concomitant Brugada syndrome substrate ablation and epicardial abdominal cardioverter-defibrillator implantation in a child  Carlo de Asmundis, MD, PhD,

Concomitant Brugada syndrome substrate ablation and epicardial abdominal cardioverter-defibrillator implantation in a child  Carlo de Asmundis, MD, PhD,

Similar presentations

Ads by Google